Peak6 Investments LLC Bridge Bio Pharma, Inc. Call Options Transaction History

Peak6 Investments LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$23.91 - $31.3 $884,670 - $1.16 Million	37,000 Added 211.43%	54,500 $1.39 Million
Q2 2024 Aug 13, 2024	BUY	$23.0 - $31.04 $347,300 - $468,704	15,100 Added 629.17%	17,500 $443,000
Q1 2024 May 14, 2024	BUY	$27.35 - $40.45 $65,640 - $97,080	2,400 New	2,400 $74,000
Q3 2023 Nov 13, 2023	BUY	$16.89 - $35.01 $1.44 Million - $2.98 Million	85,000 New	85,000 $2.24 Million
Q1 2021 May 14, 2021	SELL	$55.47 - $72.35 $715,563 - $933,314	-12,900 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$38.38 - $71.11 $495,102 - $917,319	12,900 New	12,900 $917,000

290

170M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.23B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.